Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.90

€1.90

-6.340%
-0.13
-6.340%
€6.95

€6.95

 
31.07.26 / Tradegate WKN: A2AR5F / Symbol: ACIU / Name: AC Immune / Stock / Biotechnology & Medical Research / Micro Cap /
Latest predictions
01.07.26
-6.21%
buy
€6.99
16.03.26
-32.24%
buy
13.03.26
-27.88%
buy
11.12.25
-40.03%
buy
€6.95
04.11.25
-32.00%
buy
25.09.25
-16.31%
buy
Your prediction

AC Immune Ltd Stock

Heavy losses for AC Immune Ltd today as the stock fell by -€0.130 (-6.340%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on AC Immune Ltd.
Based on the current price of 1.9 € the target price of 6 € shows a potential of 215.13% for AC Immune Ltd which would more than double the current price.
For the coming years our community has positive and negative things to say abot the AC Immune Ltd stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.

Pros and Cons of AC Immune Ltd in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

AC Immune (ACIU) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for ACIU provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -32.24%
Target price 6.988
Change
Ends at 16.03.27

AC Immune (ACIU) had its "buy" rating reaffirmed by BTIG Research. They now have a $8.00 price target on the stock.
Ratings data for ACIU provided by MarketBeat
Show more

AC Immune (ACIU) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for ACIU provided by MarketBeat
Show more